secwatch.observer — SEC 8-K summary
======================================

Issuer:     ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
CIK:        0001688757
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001688757-24-000022
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Establishment Labs Q4 revenue falls 28% YoY to $31.6M; guides 2024 rev up 5-11% to $174-184M
--------------------------------------------------------------------------------

- Q4 revenue $31.6M vs $43.8M prior year; net loss from operations $22.1M vs $13.2M.
- Adjusted EBITDA loss of $17.3M in Q4 vs $8.9M loss a year ago.
- 2024 revenue guidance $174-184M (+5-11%); excludes US Motiva Implants revenue expected in 2024.
- Proforma cash $90M after Jan $50M private placement; Oaktree facility amended for up to $50M post-FDA approval.
- Launched Motiva Implants in China; first US commercial procedure with Motiva Flora tissue expander.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1688757/000168875724000022/0001688757-24-000022-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1688757/000168875724000022/esta-20240228.htm
  HTML page:      https://secwatch.observer/filing/0001688757-24-000022

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer